“Trojan peptide” vaccine turns body against cancer

Published



A possible cure for some types of mouth, larynx and throat cancer is being tested at the University of Maryland Medical Center.

University researchers have begun testing “Trojan peptide” vaccines to treat squamous cell carcinoma, a common type of head and neck cancer. The vaccine targets specific proteins made by tumors, and in theory can stimulate the body?s immune system to destroy the cancer.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.